» Articles » PMID: 24964402

Identification of Novel Inhibitors That Disrupt STAT3-DNA Interaction from a γ-AApeptide OBOC Combinatorial Library

Overview
Specialty Chemistry
Date 2014 Jun 26
PMID 24964402
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

From a γ-AApeptide-based one-bead-one-compound (OBOC) combinatorial library, we identified γ-AApeptides that can selectively inhibit STAT3-DNA interaction and suppress the expression levels of STAT3 target genes in intact cells. Our results demonstrate that in addition to the SH2 domain, the DNA binding domain of STAT3 is targetable for the development of a new generation of anti-cancer therapeutics.

Citing Articles

The folding propensity of α/sulfono-γ-AA peptidic foldamers with both left- and right-handedness.

Teng P, Zheng M, Cerrato D, Shi Y, Zhou M, Xue S Commun Chem. 2023; 4(1):58.

PMID: 36697518 PMC: 9814141. DOI: 10.1038/s42004-021-00496-0.


Rational Design of Right-Handed Heterogeneous Peptidomimetics as Inhibitors of Protein-Protein Interactions.

Shi Y, Sang P, Lu J, Higbee P, Chen L, Yang L J Med Chem. 2020; 63(21):13187-13196.

PMID: 33140956 PMC: 8170677. DOI: 10.1021/acs.jmedchem.0c01638.


Aggregation-Induced Emissive and Circularly Polarized Homogeneous Sulfono-γ-AApeptide Foldamers.

Shi Y, Sang P, Yin G, Gao R, Liang X, Brzozowski R Adv Opt Mater. 2020; 8(14).

PMID: 33072491 PMC: 7567131. DOI: 10.1002/adom.201902122.


γ-AApeptides-based Small Molecule Ligands That Disaggregate Human Islet Amyloid Polypeptide.

Bolarinwa O, Li C, Khadka N, Li Q, Wang Y, Pan J Sci Rep. 2020; 10(1):95.

PMID: 31919432 PMC: 6952368. DOI: 10.1038/s41598-019-56500-0.


Stabilization of lncRNA GAS5 by a Small Molecule and Its Implications in Diabetic Adipocytes.

Shi Y, Parag S, Patel R, Lui A, Murr M, Cai J Cell Chem Biol. 2019; 26(3):319-330.e6.

PMID: 30661991 PMC: 10498384. DOI: 10.1016/j.chembiol.2018.11.012.


References
1.
Page B, Ball D, Gunning P . Signal transducer and activator of transcription 3 inhibitors: a patent review. Expert Opin Ther Pat. 2010; 21(1):65-83. DOI: 10.1517/13543776.2011.539205. View

2.
Lavecchia A, Di Giovanni C, Cerchia C . Novel inhibitors of signal transducer and activator of transcription 3 signaling pathway: an update on the recent patent literature. Expert Opin Ther Pat. 2014; 24(4):383-400. DOI: 10.1517/13543776.2014.877443. View

3.
Mandal P, Liao W, McMurray J . Synthesis of phosphatase-stable, cell-permeable peptidomimetic prodrugs that target the SH2 domain of Stat3. Org Lett. 2009; 11(15):3394-7. PMC: 2836187. DOI: 10.1021/ol9012662. View

4.
Cheng F, Wang H, Horna P, Wang Z, Shah B, Sahakian E . Stat3 inhibition augments the immunogenicity of B-cell lymphoma cells, leading to effective antitumor immunity. Cancer Res. 2012; 72(17):4440-8. PMC: 3990429. DOI: 10.1158/0008-5472.CAN-11-3619. View

5.
Urlam M, Pireddu R, Ge Y, Zhang X, Sun Y, Lawrence H . Development of new -Arylbenzamides as STAT3 Dimerization Inhibitors. Medchemcomm. 2013; 4(6):932-941. PMC: 3780559. DOI: 10.1039/C3MD20323A. View